Keyword: Pharmasset

News

Former Bristol-Myers Executive Admits to Insider Trading

11.06.2013 - A former Bristol-Myers Squibb finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the...

News

Biotech Firms Evolve from Targets to Acquirers

08.05.2013 - Biotechnology companies that just a short time ago were viewed as takeover targets are now more likely to be buyers themselves after seeing their valuations soar on promising new...

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

Biotech M&A at 4-Year High as Pharma Faces Expiring Patents

03.08.2012 - Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...

News

Bristol-Myers Executive Charged with Insider Trading

02.08.2012 - A Bristol-Myers Squibb executive has been criminally charged with insider trading, accused of buying options in three companies that the drugmaker was looking to buy. Prosecutors...